Cardiology

I am interested in clinical research centered on cardiac imaging and valve disease.

My research interest is in the relationship of clinical outcomes in Hypertrophic cardiomyopathy patients with their cardiac imaging findings. My clinical interests include, the care of patients with hypertrophic cardiomyopathy, family history of sudden cardiac death, left ventricular hypertrophy, valvular heart disease, coronary artery disease and preoperative cardiac evaluation.

Cardiovascular healthcare quality, outcomes reserach, Hypertrophic cardiomyopathy, Valve disease, heart failure

Acute myocardial infarction, Angioplasty, Coronary disease, Interventional cardiology, Rotablator, Stents

Dr. Lloyd-Jones attended Swarthmore College for his BA (Major in History), Columbia University College of Physicians & Surgeons for his MD, and Harvard School of Public Health for his Master of Science (Epidemiology). He was a resident, chief resident and cardiology fellow at Massachusetts General Hospital, and junior faculty at Harvard Medical School. In 2004, he moved to Northwestern and in 2009, he became Chair of the Department of Preventive Medicine. In 2012, he also became Senior Associate Dean for Clinical and Translational Research and Director of the NUCATS Institute.

Dr. Flaherty is an associate professor of medicine in Interventional Cardiology and severes as the medical director of the coronary care unit (CCU) of Northwestern Memorial Hospital. He is board certified in internal medicine, cardiovascular disease, interventional cardiology and advanced heart failure & transplant cardiology. He has severed as the principal investigator for several research trials, including those related to heart valve therapies. He is the course director for the CME conference: Chicago Case-Based Coronary & Structural Heart Intervention Update. In 2012, he was a recipient o...

Lipid metabolism, cardiovascular nutrition; premature coronary heart disease

Major Research Interests: Molecular Basis of Organ Fibrosis: Development of Epigenetic Fibrosis Therapy. Hyperactivity of differentiated fibroblasts causes an excessive synthesis and deposition of extracellular matrix proteins in the tissues that leads to organ fibrosis, a major cause of disease-related morbidity and mortality worldwide. Fibrosis is a common end-stage pathological symptom of a wide spectrum of injury or stress related multi-organ diseases such as hypertension-induced accelerated cardiac and renal aging, myocardial infarction, liver cirrhosis, systemic sclerosis and idiopathic ...